During the last session, ARS Pharmaceuticals Inc (NASDAQ:SPRY)’s traded shares were 0.52 million, with the beta value of the company hitting 0.90. At the end of the trading day, the stock’s price was $8.35, reflecting an intraday gain of 3.21% or $0.26. The 52-week high for the SPRY share is $11.27, that puts it down -34.97 from that peak though still a striking 69.46% gain since the share price plummeted to a 52-week low of $2.55. The company’s market capitalization is $805.78M, and the average trade volume was 689.74K shares over the past three months.
ARS Pharmaceuticals Inc (NASDAQ:SPRY) trade information
ARS Pharmaceuticals Inc (SPRY) registered a 3.21% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.21% in intraday trading to $8.35, hitting a weekly high. The stock’s 5-day price performance is -1.42%, and it has moved by -16.16% in 30 days. Based on these gigs, the overall price performance for the year is 28.46%.
ARS Pharmaceuticals Inc (SPRY) estimates and forecasts
Statistics show that ARS Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. ARS Pharmaceuticals Inc (SPRY) shares have gone up 139.94% during the last six months, with a year-to-date growth rate less than the industry average at -21.05% against 10.40. In the rating firms’ projections, revenue will increase 17,700.00% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -1.44%. While earnings are projected to return -17.19% in 2024.
SPRY Dividends
ARS Pharmaceuticals Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
